Protein engineering approaches for antibody fragments: directed evolution and rational design approaches - PubMed
- ️Tue Jan 01 2019
Protein engineering approaches for antibody fragments: directed evolution and rational design approaches
Merve Arslan et al. Turk J Biol. 2019.
Abstract
The number of therapeutic antibodies in preclinical, clinical, or approved phases has been increasing exponentially, mostly due to their known successes. Development of antibody engineering methods has substantially hastened the development of therapeutic antibodies. A variety of protein engineering techniques can be applied to antibodies to improve their afinity and/or biophysical properties such as solubility and stability. Antibody fragments (where all or some parts of constant regions are eliminated while the essential antigen binding region is preserved) are more suitable for protein engineering techniques because there are many in vitro screening technologies available for antibody fragments but not full-length antibodies. Improvement of biophysical characteristics is important in the early development phase because most antibodies fail at the later stage of development and this leads to loss of resources and time. Here, we review directed evolution and rational design methods to improve antibody properties. Recent developments in rational design approaches and antibody display technologies, and especially phage display, which was recently awarded the 2018 Nobel Prize, are discussed to be used in antibody research and development.
Keywords: Antibody; afinity; antibody fragment; biophysical properties; directed evolution; phage display; protein engineering; rational design; yeast surface display.
Conflict of interest statement
CONFLICT OF INTEREST: none declared
Figures

Antibody display technologies. General schematic for in vitro and in vivo display techniques.

Protein engineering approaches based on antibody regions. While solubility/ aggregation can be improved by engineering exposed residues, stability can be increased by both exposed and core residues. Complementarity-determining regions (CDRs) mainly affect specificity and affinity. Tags/linkers can be added for better functionality.

A case study for web tools. Several tools introduced in this review were used to determine aggregation-prone regions of an scFv sequence used in our lab. Blue highlighted regions are outputs of tools as aggregation prone regions. Each web tool has a different threshold, which was not shown in this figure. Mutation site is selected according to common predicted regions of different tools (at least 6 of 8 tools gave same residues as aggregation-prone).
Similar articles
-
Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms.
Kang TH, Seong BL. Kang TH, et al. Front Microbiol. 2020 Sep 25;11:1927. doi: 10.3389/fmicb.2020.01927. eCollection 2020. Front Microbiol. 2020. PMID: 33101218 Free PMC article. Review.
-
Beck-Sickinger AG. Beck-Sickinger AG. Internist (Berl). 2019 Oct;60(10):1014-1020. doi: 10.1007/s00108-019-00675-1. Internist (Berl). 2019. PMID: 31541280 Review. German.
-
Kaleli NE, Karadag M, Kalyoncu S. Kaleli NE, et al. Proteins. 2019 Jul;87(7):607-618. doi: 10.1002/prot.25685. Epub 2019 Apr 9. Proteins. 2019. PMID: 30883916
-
Phage display-derived human antibodies in clinical development and therapy.
Frenzel A, Schirrmann T, Hust M. Frenzel A, et al. MAbs. 2016 Oct;8(7):1177-1194. doi: 10.1080/19420862.2016.1212149. Epub 2016 Jul 14. MAbs. 2016. PMID: 27416017 Free PMC article. Review.
-
Therapeutic Antibodies by Phage Display.
Shim H. Shim H. Curr Pharm Des. 2016;22(43):6538-6559. doi: 10.2174/1381612822666160923113714. Curr Pharm Des. 2016. PMID: 27669967 Review.
Cited by
-
Aggidis A, Devitt G, Zhang Y, Chatterjee S, Townsend D, Fullwood NJ, Ortega ER, Tarutani A, Hasegawa M, Cooper A, Williamson P, Mendoza-Oliva A, Diamond MI, Mudher A, Allsop D. Aggidis A, et al. Alzheimers Dement. 2024 Nov;20(11):7788-7804. doi: 10.1002/alz.14246. Epub 2024 Oct 3. Alzheimers Dement. 2024. PMID: 39360630 Free PMC article.
-
Protein-based lateral flow assays for COVID-19 detection.
Mahmoudinobar F, Britton D, Montclare JK. Mahmoudinobar F, et al. Protein Eng Des Sel. 2021 Feb 15;34:gzab010. doi: 10.1093/protein/gzab010. Protein Eng Des Sel. 2021. PMID: 33991088 Free PMC article. Review.
-
Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis.
Duranti C, Arcangeli A. Duranti C, et al. Antibodies (Basel). 2019 May 24;8(2):33. doi: 10.3390/antib8020033. Antibodies (Basel). 2019. PMID: 31544839 Free PMC article. Review.
-
Karimi Baba Ahmadi M, Mohammadi SA, Makvandi M, Mamoueie M, Rahmati M, Wood D. Karimi Baba Ahmadi M, et al. Protein Expr Purif. 2020 Oct;174:105650. doi: 10.1016/j.pep.2020.105650. Epub 2020 Apr 29. Protein Expr Purif. 2020. PMID: 32360597 Free PMC article.
-
MutDock: A computational docking approach for fixed-backbone protein scaffold design.
Chauhan VM, Pantazes RJ. Chauhan VM, et al. Front Mol Biosci. 2022 Aug 29;9:933400. doi: 10.3389/fmolb.2022.933400. eCollection 2022. Front Mol Biosci. 2022. PMID: 36106019 Free PMC article.
References
-
- Agrawal NJ , Kumar S , Wang XL , Helk , B , Singh SK , Trout BL ( 2011. ). Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone Regions . Journal of Pharmaceutical Sciences 100 : 5081 - 5095 . - PubMed
-
- Beerten J , Van Durme J , Gallardo R , Capriotti E , Serpell L , Rousseau F , Schymkowitz J ( 2015. ). WALTZ-DB: a benchmark database of amyloidogenic hexapeptides . Bioinformatics 31 : 1698 - 1700 . - PubMed
-
- Bradbury A , Pluckthun A ( 2015. ). Standardize antibodies used in research . Nature 518 : 27 - 29 . - PubMed
-
- Brodel AK , Isalan M , Jaramillo A ( 2018. ). Engineering of biomolecules by bacteriophage directed evolution . Current Opinion in Biotechnology 51 : 32 - 38 . - PubMed
LinkOut - more resources
Full Text Sources